SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-22-004401
Filing Date
2022-06-15
Accepted
2022-06-15 16:00:39
Documents
16
Period of Report
2022-06-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ipix_8k.htm   iXBRL 8-K 31397
2 SERIES A PREFERRED SHARE PURCHASE AGREEMENT ipix_ex101.htm EX-10.1 415541
3 PRESS RELEASE ipix_ex991.htm EX-99.1 16571
  Complete submission text file 0001477932-22-004401.txt   679360

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ipix-20220609.xsd EX-101.SCH 5845
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20220609_lab.xml EX-101.LAB 13255
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20220609_cal.xml EX-101.CAL 908
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20220609_pre.xml EX-101.PRE 8343
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20220609_def.xml EX-101.DEF 2113
10 EXTRACTED XBRL INSTANCE DOCUMENT ipix_8k_htm.xml XML 3293
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 221017751
SIC: 2834 Pharmaceutical Preparations